Symptoms of multiple sclerosis in women in relation to sex steroid exposure

Maturitas

Volumn 54, Issue 2, 2006, Pages 149-153

  Holmqvist, Per ^a,b   Wallberg, Malin ^a   Hammar, Mats ^a   Landtblom, A M ^a   Brynhildsen, Jan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Sundsvall County Hospital   (Sweden)

Author keywords

Hormone therapy; Immunology; Menopause; Multiple sclerosis; Oestrogen

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ADULT; AGED; ARTICLE; DELIVERY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOLOGY; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUATION; MULTIPLE SCLEROSIS; ORAL CONTRACEPTION; POSTMENOPAUSE; PREGNANCY; PUERPERIUM; QUESTIONNAIRE; SWEDEN;

ADULT; AGED; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MIDDLE AGED; MULTIPLE SCLEROSIS; POSTPARTUM PERIOD; PREGNANCY;

EID: 33748075167     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.10.003     Document Type: Article

References (18)

1. Martin R., and McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32 (1995) 121-182
2. Duquette P., and Girard M. Hormonal factors in susceptibility to multiple sclerosis. Curr Opin Neurol Neurosurg 6 (1993) 195-201
3. Östenson M., Aune B., and Husby G. Effects of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 12 (1983) 69-72
4. Hutchinson M. Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry 56 (1993) 1043-1045
5. Damek D.M., and Shuster E.A. Pregnancy and multiple sclerosis. Mayo Clin Proc 72 (1997) 977-989
6. Confavreuex C., Hutchinson M., Hours M.M., Cortinovis-Touniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339 (1998) 285-291
7. Bernardi S., Grasso M.G., Bertollini R., Orzi F., and Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand 84 (1991) 403-406
8. Correale J., Gilmore W., McMillan M., et al. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 154 (1995) 2959-2968
9. Formby B. Immunologic response in pregnancy. Endocrinol Metabol Clin N Am 24 (1995) 187-205
10. Faas M., Bouman A., Moes H., Heineman M.J., de Leij L., and Schilling G. The immune response during the luteal phase of the ovarian cycle: a Th2-type response?. Fertil Steril 74 (2000) 1008-1013
11. Sicotte N.L., Silva S.M., Klutch R., et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52 (2002) 421-428
12. Smith R., and Studd J.W.W. A pilot study of the effect upon multiple sclerosis of the menopause, hormone therapy and the menstrual cycle. J R Soc Med 85 (1992) 612-613
13. Bansil S., Lee H.J., Jindahl S., Holtz C.R., and Cook S.D. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand 99 (1999) 91-94
14. Pozilli C., Falaschi P., Mainero C., et al. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology 53 (1999) 622-624
15. Hernan M.A., Hohol M.J., Olek M.J., Spiegelman D., and Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 55 (2000) 848-853
16. Thorogood M., and Hannaford P.C. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105 (1998) 1296-1299
17. Hemminki E., Brambilla D.J., McKinlay S.M., and Posner J.G. Use of estrogens among middle-aged Massachusetts women. DICP 25 (1991) 418-423
18. Zorgdrager A., and De Keyser J. J Neurol Sci 149 1 (1997) 95-97